Preparing for the Medicare GLP-1 Bridge Program

Overview

The upcoming GLP-1 Bridge Program, which starts on July 1^st, represents a significant development in how Medicare members may gain access to certain anti-obesity medications. Historically, drugs used for weight loss have been excluded from Medicare Part D coverage. The Bridge program is anticipated to serve as an interim pathway to expand access while broader policy changes are evaluated. CMS has hosted several public educational sessions for the industry in order to educate pharmacies, prescribers and plans on the basics of the program.

Key Distinction: Outside the Medicare Benefit

It is critical to clearly communicate that the GLP-1 Bridge Program is not a standard Medicare Part D benefit. These medications are not expected to be covered under plan formularies, processed through typical benefit adjudication systems, or subject to standard prior authorization requirements. Despite this, members will still look to their health plan and pharmacy benefit manager (PBM) for guidance. The operational component of the program will be handled by a central processor and all prescriber submissions and approvals will be handled through that process. Pharmacies will adjudicate these claims through a unique BIN/PCN which will keep the dispensing separate from all other Part D claims. CMS has also stated that if Medicare members contact the plan inquiring about the program, they can be referred to 1-800-Medicare.

Operational Impact on Call Centers

Plans and PBMs should anticipate the following:

• Increased inquiry volume regarding GLP-1 medication access
• Member confusion about whether these drugs are covered under their plan
• Requests for formulary exceptions, prior authorization, or cost-sharing details that may not apply

Why Call Center Education is Critical

Even though the GLP-1 Bridge Program sits outside of the Medicare benefit, plan call centers may serve as the frontline resource for members. Without proper education and scripting, there is a heightened risk of inconsistent messaging, member dissatisfaction, and potential compliance concerns.

Recommended Actions for Plans and PBMs

Organizations should take immediate steps to prepare:

• Clear messaging that distinguishes between Part D coverage and the Bridge program
• Update call center scripts and knowledge base materials to reflect accurate information
• Train customer service representatives on how to respond to GLP-1 inquiries
• Establish escalation pathways for complex or unclear member questions
• Align all communications with compliance and regulatory guidance

Bottom Line

The GLP-1 Bridge Program represents a new access pathway that exists outside of the Medicare benefit structure. However, member expectations will not differentiate between program types. Plans and PBMs must proactively educate their call centers to ensure accurate guidance, minimize confusion, and maintain a compliant, consistent member experience.